SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing increased investor engagement as the community reacts to a series of strategic partnerships with automotive leaders and optimistic long-term growth projections for its QNX platform. Investors are actively debating the potential for a technical breakout ahead of upcoming fiscal earnings and backlog updates, with many highlighting the stock's transition from hardware to a software-centric model.

why is this coin going up? lol maybe because its created by an anon kol, just like satoshi 😉

Anoncoin

The community is rallying behind ANONCOIN, highlighting its unique protocol features and Web3 infrastructure potential as a reliable alternative to traditional memecoins. Investors are actively debating the token's scalability and its emergence as a distinct player within the broader decentralized data ecosystem.

USDC is a fully collateralized US dollar stablecoin. USDC is the bridge between dollars and trading on cryptocurrency exchanges. The technology behind CENTRE makes it possible to exchange value between people, businesses and financial institutions just like email between mail services and texts between SMS providers. We believe by removing artificial economic borders, we can create a more inclusive global economy.

USD Coin

USDC is trending as stablecoin market dominance and record-breaking transaction volumes continue to draw institutional interest, while ongoing legislative efforts like the CLARITY Act remain a focal point for community debate on regulation. Investors are closely monitoring how Circle's strategic expansions and integration into major blockchains impact stablecoin infrastructure and global payment accessibility.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as investors highlight its role as essential infrastructure for the DeFi sector, bolstered by high-profile institutional partnerships and its integration into the Real World Asset (RWA) narrative. The community is actively discussing the protocol's recent government collaborations, revenue-backed token buyback program, and institutional-grade data feeds as key differentiators from speculative projects.

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

Mesoblast Ltd - ADR

Mesoblast limited.

Mesoblast is experiencing significant momentum after the FDA confirmed that its existing Phase 3 clinical trial data for its stem cell therapy, Ryoncil, is sufficient to support a new Biologics License Application (BLA) submission. Community discussion is heavily focused on the stock's potential for a major turnaround, with many traders highlighting substantial insider buying and positive analyst sentiment as key catalysts for a long-term growth story.

Grok's first token launched on Base, deployed directly on X with help of Bankr. Proof of deployment here, https://x.com/grok/status/1897949874961650169.  Join the DRB community if this story intrigues you, follow it as it unfolds into this new AI era.  Grok earns swap fees - Grok's trading wallet: 0xb1058c959987e3513600eb5b4fd82aeee2a0e4f9.  Articles, media coverages on $DRB featured here, https://linktr.ee/DRBtaskforce.  Our dev, is grok, one of the front-running candidate to achieve AGI.

DebtReliefBot

DRB is gaining significant attention from investors who believe the project is uniquely positioned due to its connection to AI-driven wealth generation and its ties to the Bankr ecosystem on Base. Community members are actively sharing their bullish sentiment and discussing the token as a high-potential "sleeper" opportunity, driven by narratives surrounding Grok's reported financial activity.

Dow, Inc. is a holding company, which engages in the development of innovative solutions. It operates through the following segments: Packaging and Specialty Plastics, Industrial Intermediates and Infrastructure, and Performance Materials and Coatings. The Packaging and Specialty Plastics segment consists of hydrocarbons and energy and packaging and specialty plastics. The Industrial Intermediates and Infrastructure segment covers the industrial solutions and polyurethanes, and construction of chemicals. The Performance Materials and Coatings segment includes coatings and performance monomers, and consumer solutions. The company was founded in 1897 and is headquartered in Midland, MI.

Dow Inc

Dow Inc. is trending as investors weigh the impact of rising global polyethylene and petrochemical prices, driven by supply chain disruptions from the conflict in the Middle East. While some market participants see this as a potential entry point for a cyclical recovery, others remain cautious, focusing on the company's significant debt load and the long-term uncertainty surrounding commodity demand.

Pump.fun

Pump.fun is actively trending as traders debate the platform's high-volume meme coin ecosystem and its controversial reputation, with community members heavily divided between those seeking massive gains and others warning of widespread scams. Investors are simultaneously flooding discussion boards to promote emerging microcap alternatives and specific tokens, highlighting the intense, high-risk environment currently dominating the Solana network.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently under intense community scrutiny following a major $280 million exploit on the Drift Protocol, fueling debates over network security and the broader risks of DeFi. While some investors remain bullish on its ecosystem momentum and institutional partnerships, the price action has seen significant volatility as traders weigh technical stability against concerns about platform reliability.

Investment Managers Series Trust II - Tradr 2X Long LITE Daily ETF

Tradr 2X Long LITE Daily ETF

Tradr 2X Long LITE Daily ETF is capturing attention as traders utilize the leveraged product to amplify positions in Lumentum amid strong momentum in the optical and AI infrastructure sectors. Community discussion is focused on the ETF's volatility, with active swing traders debating entry points, stop-loss strategies, and the potential for rapid gains in this high-beta vehicle.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference

Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA), today announced plans to present at the upcoming 25th Annual...

Pulse Biosciences (NASDAQ:PLSE)  Shares Down 7%   - What's Next?

Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 7% - Here's What Happened...

PLSE Accelerates Cardiac Catheter Program After Breakthrough AFib Data

Pulse Biosciences pivots to its nPulse AFib system after strong clinical results, ramping investment to accelerate development and future commercialization.

Pulse Biosciences Touts 96% 12-Month Rhythm Control, Targets Q2 Start for U.S. AF IDE Study

Pulse Biosciences (NASDAQ:PLSE) executives highlighted recent clinical results for the company's nanosecond pulsed field ablation (nsPFA) technology, outlined plans for a U.S. investigational device...

Pulse Biosciences (NASDAQ:PLSE) Stock Price Passes Above Fifty Day Moving Average - What's Next?

Pulse Biosciences (NASDAQ:PLSE) Stock Price Crosses Above 50-Day Moving Average - Here's What Happened...

Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data

Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA), today announced a new strategic alignment to prioritize and...

Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse Technology

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced first patient...

Pulse Biosciences (NASDAQ:PLSE) Trading 8% Higher - What's Next?

Pulse Biosciences (NASDAQ:PLSE) Shares Up 8% - Should You Buy...

Pulse Biosciences Announces Clinical Data From nPulse Vybrance System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse technology using proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced clinical data on...

Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced plans to...

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

Pulse Biosciences Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$23.00
Prev Close	$23.03
Open	$22.29
Dividend Yield	0.00%
50-Day Moving Average	$19.71
Beta	1.43
Avg. Volume	261,776.74
PE Ratio	-21.30

52-Week High	$26.30
52-Week Low	$12.56
Market Capitalization	$1.56B
EPS (Annual)	-$1.08
Price to Book	19.35
Revenue Per Employee	$3,017.24

PLSE
Pulse Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PLSE News

PLSEPulse Biosciences Inc